Efficacy of Different Immunological Approaches Targeting CD22 for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia: A Research Protocol
Posted on 2022-04-21
A new article from the URNCST Journal has been published! Read more about it here: